Calorie Restriction and GLP-1 Hormone Levels: Understanding the Relationship
Glucagon-like peptide-1 (GLP-1) is a hormone that plays a crucial role in regulating blood sugar levels, appetite, and metabolism. Its significance in weight management has led to its use in treatment of type 2 diabetes and as an anti-obesity medication. In recent years, the introduction of GLP-1 receptor agonists (RA) has been touted to revolutionize obesity management. The effects of GLP-1 hormones on calorie restriction are of particular interest, as both GLP-1 and calorie restriction-based approaches have been shown to promote weight loss.
GLP-1 Hormones and Calorie Restriction
When calorie-restrictive diets are implemented, the body responds by adjusting its hormonal balance. Specifically, calorie restriction can lead to a decrease in insulin levels, followed by an increase in sex hormone-binding globulin (SHBG) from the liver. Higher SHBG levels can, in turn, affect the body's ability to store fat, losing muscle mass during weight loss and impeding weight loss in general, understating various physical outcomes and health implications. [1] Research suggests that this hormonal response to calorie restriction can have unintended effects on overall health and body composition.
The Role of GLP-1 in Calorie Restriction
GLP-1 medications work by mimicking the natural hormone produced in the body after eating, stimulating insulin secretion and promoting weight loss. These medications can achieve weight losses of about 15–25% while being relatively well-tolerated by patients. These effects are obtained with emphasis on a caloric restricted diet and or exercises to achieve more tolerant weight losses for overall health and well-being. Inspired by the potential benefits of the approach, scientists are studying GLP-1’s action on body weight and metabolic health in both short and long-term effects for glucagon-like peptide-1 hormone support in the body altered by low calorie regimes with incremental maximum increase.
